First in vitro and in vivo experiences with stay·safe balance, a pH-neutral solution in a dual-chambered bag

Peritoneal Dialysis International

Volumn 20, Issue SUPPL. 5, 2001, Pages

  Lage, C ^a   Pischetsrieder, M ^a   Aufricht, C ^a   Jorres A ^a   Schilling, H ^a   Passlick Deetjen, J ^a  

^a FRESENIUS MEDICAL CARE   (Germany)

Author keywords

Advanced glycosylation end products; Biocompatibility; Glucose degradation products; PH neutral peritoneal dialysis solution

Indexed keywords

3 DEOXYGLUCOSONE; ACETALDEHYDE; CA 125 ANTIGEN; CARBOHYDRATE DERIVATIVE; FORMALDEHYDE; GLUCOSE DEGRADATION PRODUCT; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTIC ACID; METHYLGLYOXAL; PERITONEAL DIALYSIS FLUID; STAY SAFE BALANCE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CELL FUNCTION; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTAINER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DRUG EFFICACY; DRUG EXPOSURE; DRUG MIXTURE; DRUG STERILITY; DRUG STORAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; FEMALE; FILTER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MALE; MESOTHELIUM CELL; MULTICENTER STUDY; OSMOLARITY; PERITONEUM CELL; PH; PRESERVATION; PRIORITY JOURNAL; SHORT COURSE THERAPY;

CELLS, CULTURED; DIALYSIS SOLUTIONS; DIFFUSION CHAMBERS, CULTURE; EPITHELIAL CELLS; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYDROGEN-ION CONCENTRATION; PERITONEAL CAVITY; STERILIZATION; TIME FACTORS;

EID: 0035119578     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes
2. Toxicity of effluent peritoneal dialysis fluid
3. In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis
4. Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro?
5. Reduced glucose degradation products in bicarbonate/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags
6. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorpho-nuclear cell function in vitro
7. Effects of pH 7.4, lactate-based and a pH 7.4, bicarbonate-based peritoneal dialysis solution on neutrophil superoxide generation
8. Effect of glucose degradation products on human peritoneal mesothelial cell function
9. Kinetics and dose response of the effects of heated glucose peritoneal dialysis fluids on the respiratory burst of rat peritoneal leukocytes
10. Heat-sterilized PD fluid blocks leukocyte adhesion and increases flow velocity of rat peritoneal venules
11. Effects of acidity, glucose degradation products, and dialysis fluid buffer choice on peritoneal solute and fluid transport in rats
12. 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for dialysis
13. In vitro formation of advanced glycation end products in peritoneal dialysis fluid
14. Heat sterilization of PD fluid promotes advanced glycation end-product (AGE) formation
15. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids
16. Effects of 3-deoxyglucosone on the Maillard reaction
17. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD
18. Accumulation of advanced glycation end products in the peritoneal vasculature of continous ambulatory peritoneal dialysis patients with low ultra-filtration
19. Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds
20. Formation of the glucose degradation product 3-deoxyglucosone and other carbonyl-compounds in single- or double-chamber peritoneal dialysis fluids
21. A new lactate-based, plasticizer-free, neutral peritoneal dialysis fluid provided in a two-compartment system: Effect on peripheral leukocyte function
22. Mesothelial biocompatibility of Balance, a novel two-chambered, lactate-buffered peritoneal dialysis solution
23. Reduced viability of human peritoneal mesothelial cells (HPMC) following "chronic" exposure to differently sterilized peritoneal fluids (PDF)
24. ε-(carboxy-methyl) lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis (CAPD)
25. Führt die CAPD-stay-safe-balance-Lösung zu einer Erhöhung der Mesothelzellmasse?